LONDON--In an interview with Reuters here earlier this month, Alex Titomirov, president and CEO of the information technology company InforMax, said the firm will soon open sales offices in London and Germany to expand its presence in the European drug-development software market. The US-based company, which opened a Paris office last year, will nearly double its staff to around 70 this year in an effort to compete with such entrenched European players as Oxford Molecular Group and MDL Information Systems, Titomirov revealed.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.